MedTrace Logo

Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome

NCT04087200 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2019-09-12

No results posted yet for this study

Summary

Registration of all ACS patients (STEMI and NSTEMI) admitted to the cardiology ward and scheduled for early invasive strategy. The aim is to evaluate the protective effects of early (on admission) high-dose high-potency statin therapy on early and mid-term cardiac and renal events in this subset of patients.

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

  • Azienda USL 4 Prato

    collaborator OTHER

  • Centro Cardiopatici Toscani

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2025-12-01
Completion
2026-12-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04087200 on ClinicalTrials.gov